New foam aims to soothe stubborn eczema in final test phase
NCT ID NCT07173478
Summary
This study is testing if a new foam containing the drug OPA-15406 is better than a foam without the drug at improving skin in adults with moderate atopic dermatitis (eczema). About 156 participants will apply the foam to their skin for 4 weeks. The main goal is to see if the active foam clears or almost clears the skin for more people than the placebo foam.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
Locations
-
Mita Dermatology Clinic
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.